With ChIP-chip and CAGE (cap analysis of gene expression) analysis, which are advanced high-throughput techniques, several new AR target genes, including TRIM36, have been identified in the whole genome of prostate cancer cells14–16. The gene discussed is TRIM36; the disease is prostate carcinoma.